1.
Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study.
Tanihara Hidenobu, Yamamoto Tetsuya, Aihara Makoto, Koizumi Noriko, Fukushima Atsuki, Kawakita Koji et al.
Graefes Arch Clin Exp OphthalmolMar 20245 citationsClinical Trial
This study found ripasudil-brimonidine fixed-dose combination significantly lowered intraocular pressure long-term, alone or with other glaucoma medications, offering a new treatment option despite common mild ocular side effects.